Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CYTOKINETICS INCCYTK · Entity 3528 | Director · President & CEO | October 12, 2026 | October 13, 2026 |
| Gamida Cell Ltd.GMDA · Entity 94655 | Director | February 08, 2023 | February 11, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CYTOKINETICS INC
Report date October 12, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 278,544 |
Ending reported balance
After 2026-10-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-10-12 · Exercise / conversion · Acquired 7,500 · Balance 286,044 Row 2 · 2026-10-12 · Sale · Disposed 7,500 · Balance 278,544 |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.60 · Expires 2027-02-28 | Direct | 141,745 |
Reported balance
After 2026-10-12 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-10-12 · Exercise / conversion · Disposed 7,500 · Balance 141,745 |
| Common StockSEC Table I · non-derivative | Indirectby Trust 1. Beneficial Ownership disclaimed. | 2,083 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 2,083 F1: Shares held by The Bridget Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares. |
| Common StockSEC Table I · non-derivative | Indirectby Trust 2. Beneficial Ownership Disclaimed. | 2,083 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 2,083 F2: Shares held by The Brittany Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held by The Bridget Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
F2: Shares held by The Brittany Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
Gamida Cell Ltd.
Report date February 08, 2023 · Filed February 11, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 96,500 |
Ending reported balance
After 2023-02-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-02-08 · Grant · Acquired 28,300 · Balance 82,300 F1: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date. Row 2 · 2023-02-08 · Grant · Acquired 14,200 · Balance 96,500 F1: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date. |
| Share Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.59 · Expires 2033-02-07 | Direct | 56,600 |
Reported balance
After 2023-02-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-02-08 · Grant · Acquired 56,600 · Balance 56,600 F2: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date. |
| Share Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.59 · Expires 2033-02-07 | Direct | 28,300 |
Reported balance
After 2023-02-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-02-08 · Grant · Acquired 28,300 · Balance 28,300 F2: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date.
F2: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 16, 2025 Filed Oct 16, 2025 21:05 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $60.03 | $300,150.00 |
DisclosureSEC source: 0001061983-25-000016 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 363,108 Read SEC document |
| October 01, 2025 Filed Oct 1, 2025 20:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $55.05 | $275,250.00 |
DisclosureSEC source: 0001061983-25-000007 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 368,108 Read SEC document |
| September 15, 2025 Filed Sep 15, 2025 20:47 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $49.77 | $248,850.00 |
DisclosureSEC source: 0001061983-25-000004 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 373,108 Read SEC document |
| September 02, 2025 Filed Sep 2, 2025 20:31 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $48.76 | $243,800.00 |
DisclosureSEC source: 0001127602-25-021070 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 378,108 Read SEC document |
| August 15, 2025 Filed Aug 15, 2025 20:23 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $38.42 | $192,100.00 |
DisclosureSEC source: 0001127602-25-020507 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 383,108 Read SEC document |
| July 29, 2025 Filed Jul 31, 2025 20:38 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $36.45 | $182,250.00 |
DisclosureSEC source: 0001127602-25-019804 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 388,108 Read SEC document |
| July 14, 2025 Filed Jul 15, 2025 21:38 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $38.15 | $190,750.00 |
DisclosureSEC source: 0001127602-25-019221 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 393,108 Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 19:51 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $33.55 | $167,750.00 |
DisclosureSEC source: 0001127602-25-018622 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 398,108 Read SEC document |
| June 16, 2025 Filed Jun 16, 2025 21:19 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $33.80 | $169,000.00 |
DisclosureSEC source: 0001127602-25-017580 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 403,108 Read SEC document |
| June 02, 2025 Filed Jun 2, 2025 20:33 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $31.22 | $156,100.00 |
DisclosureSEC source: 0001127602-25-016207 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 408,108 Read SEC document |
| May 16, 2025 Filed May 16, 2025 20:23 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $30.93 | $154,650.00 |
DisclosureSEC source: 0001127602-25-014700 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 412,629 Read SEC document |
| April 29, 2025 Filed Apr 29, 2025 20:33 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $40.96 | $204,800.00 |
DisclosureSEC source: 0001127602-25-012732 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 417,629 Read SEC document |
| April 10, 2025 Filed Apr 10, 2025 21:40 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $36.77 | $183,850.00 |
DisclosureSEC source: 0001127602-25-011922 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 422,629 Read SEC document |
| March 31, 2025 Filed Mar 31, 2025 20:28 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 15,000 | $40.75 | $611,250.00 |
DisclosureSEC source: 0001127602-25-010672 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 427,629 Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 00:19 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 12,648 | $44.38 | $561,318.24 |
DisclosureSEC source: 0001127602-25-009710 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,533 F1 · kind: Sell to cover transaction in connection with the vesting of restricted stock units. Read SEC document |
| March 17, 2025 Filed Mar 17, 2025 20:36 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 25,000 | $44.65 | $1,116,250.00 |
DisclosureSEC source: 0001127602-25-009695 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 339,181 Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 20:08 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 176,547 | $0.00 Strike: $44.36 | $0.00 |
DisclosureSEC source: 0001127602-25-009749 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,547 Underlying: Common Stock · 176,547 shares Expires 2035-03-13 F5 · kind: Stock options vest in equal monthly installments over 48 months from the date of grant, subject to Mr. Blum's continued employment with the company on the scheduled vesting date. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 20:08 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantIncentive Stock Option (Right to Buy) · Derivative | 2,254 | $0.00 Strike: $44.36 | $0.00 |
DisclosureSEC source: 0001127602-25-009749 · form4.xml · derivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,254 Underlying: Common Stock · 2,254 shares Expires 2035-03-13 F4 · kind: Stock options vest in equal monthly installments over 48 months from the date of grant, subject to Mr. Blum's continued employment with the company on the scheduled vesting date. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 20:08 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 116,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-009749 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 480,277 F1 · kind: Comprised of restricted stock units that convert to shares of common stock on a 1:1 basis upon vesting. 40% of the RSUs will vest on the 1-year anniversary of the date of grant; an additional 40% of the RSUs will vest on the 2-year anniversary of the date of grant; and the final 20% of the RSUs will vest on the 3-year anniversary of the date of grant, in each case subject to Mr. Blum's continued employment with the company on the scheduled vesting date. Read SEC document |
| March 06, 2025 Filed Mar 8, 2025 01:39 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 16,970 | $43.44 | $737,176.80 |
DisclosureSEC source: 0001127602-25-008790 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 364,181 F1 · kind: Sell to cover transaction in connection with vesting of restricted stock units. Read SEC document |
| March 05, 2025 Filed Mar 5, 2025 21:43 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 25,000 | $43.23 | $1,080,750.00 |
DisclosureSEC source: 0001127602-25-008331 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 381,151 Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:34 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 8,743 | $42.88 | $374,899.84 |
DisclosureSEC source: 0001127602-25-008312 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 406,151 F1 · kind: Sale to cover transaction in relation to vesting of restricted stock units. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 21:10 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 11,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-028700 · form4.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 414,894 F3 · kind: Transaction represents shares of PSUs whose performance condition was satisfied but that remain subject to time-based vesting. These PSUs to vest in full December 3, 2025. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 21:10 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 5,843 | $51.51 | $300,972.93 |
DisclosureSEC source: 0001127602-24-028700 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 403,364 F2 · kind: Transaction represents withholding of shares to satisfy grantee's tax obligations in connection with vesting PSUs. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 21:10 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 11,529 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-028700 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 409,207 F1 · kind: Transaction represents gross shares of common stock received by grantee upon vesting of Performance Stock Units ("PSUs"). Read SEC document |
| December 02, 2024 Filed Dec 2, 2024 23:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-028326 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,727 Underlying: Common Stock · 5,000 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2024 Filed Dec 2, 2024 23:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $50.76 | $253,800.00 |
DisclosureSEC source: 0001127602-24-028326 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 397,678 Read SEC document |
| December 02, 2024 Filed Dec 2, 2024 23:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.67 | $33,350.00 |
DisclosureSEC source: 0001127602-24-028326 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 402,678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 21:16 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-027633 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,727 Underlying: Common Stock · 5,000 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 21:16 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $50.55 | $252,750.00 |
DisclosureSEC source: 0001127602-24-027633 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 397,456 Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 21:16 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.67 | $33,350.00 |
DisclosureSEC source: 0001127602-24-027633 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 402,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2024 Filed Nov 4, 2024 22:45 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-026397 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,727 Underlying: Common Stock · 5,000 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2024 Filed Nov 4, 2024 22:45 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $51.63 | $258,150.00 |
DisclosureSEC source: 0001127602-24-026397 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 397,456 Read SEC document |
| November 01, 2024 Filed Nov 4, 2024 22:45 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.67 | $33,350.00 |
DisclosureSEC source: 0001127602-24-026397 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 402,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 09, 2024 Filed Oct 10, 2024 20:00 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-025384 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,727 Underlying: Common Stock · 5,000 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 09, 2024 Filed Oct 10, 2024 20:00 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $55.61 | $278,050.00 |
DisclosureSEC source: 0001127602-24-025384 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 397,456 Read SEC document |
| October 09, 2024 Filed Oct 10, 2024 20:00 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.67 | $33,350.00 |
DisclosureSEC source: 0001127602-24-025384 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 402,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2024 Filed Sep 30, 2024 22:56 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-024579 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,727 Underlying: Common Stock · 5,000 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2024 Filed Sep 30, 2024 22:56 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $52.14 | $260,700.00 |
DisclosureSEC source: 0001127602-24-024579 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 397,456 Read SEC document |
| September 30, 2024 Filed Sep 30, 2024 22:56 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.67 | $33,350.00 |
DisclosureSEC source: 0001127602-24-024579 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 402,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:10 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-024077 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,727 Underlying: Common Stock · 5,000 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:10 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $55.99 | $279,950.00 |
DisclosureSEC source: 0001127602-24-024077 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 397,456 Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:10 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.67 | $33,350.00 |
DisclosureSEC source: 0001127602-24-024077 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 402,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 21:09 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-023332 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,727 Underlying: Common Stock · 5,000 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 21:09 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $57.03 | $285,150.00 |
DisclosureSEC source: 0001127602-24-023332 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 397,456 Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 21:09 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.67 | $33,350.00 |
DisclosureSEC source: 0001127602-24-023332 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 402,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2024 Filed Aug 19, 2024 20:00 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GiftCommon Stock | 1,956 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022458 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 397,456 F1 · kind: Bona fide gift transaction. Read SEC document |
| August 12, 2024 Filed Aug 12, 2024 21:32 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 11,500 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-022027 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,727 Underlying: Common Stock · 11,500 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2024 Filed Aug 12, 2024 21:32 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 11,500 | $55.17 | $634,455.00 |
DisclosureSEC source: 0001127602-24-022027 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 399,412 Read SEC document |
| August 12, 2024 Filed Aug 12, 2024 21:32 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 11,500 | $6.67 | $76,705.00 |
DisclosureSEC source: 0001127602-24-022027 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 410,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.